Tjeerd J. Postma

8.2k total citations · 1 hit paper
78 papers, 5.3k citations indexed

About

Tjeerd J. Postma is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tjeerd J. Postma has authored 78 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 28 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Tjeerd J. Postma's work include Glioma Diagnosis and Treatment (52 papers), Brain Metastases and Treatment (21 papers) and Cancer-related cognitive impairment studies (16 papers). Tjeerd J. Postma is often cited by papers focused on Glioma Diagnosis and Treatment (52 papers), Brain Metastases and Treatment (21 papers) and Cancer-related cognitive impairment studies (16 papers). Tjeerd J. Postma collaborates with scholars based in Netherlands, United States and France. Tjeerd J. Postma's co-authors include J.J. Heimans, Martin Klein, Neil K. Aaronson, Jaap C. Reijneveld, Jan J. Heimans, Martin Klein, W. Peter Vandertop, C.C.P. Verstappen, Klaas Hoekman and Ben J. Slotman and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Tjeerd J. Postma

77 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up

2009 509 citations Linda Douw, Martin Klein et al. profile →

Peers

Countries citing papers authored by Tjeerd J. Postma

Since Specialization

Citations

This map shows the geographic impact of Tjeerd J. Postma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tjeerd J. Postma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tjeerd J. Postma more than expected).

Fields of papers citing papers by Tjeerd J. Postma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tjeerd J. Postma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tjeerd J. Postma. The network helps show where Tjeerd J. Postma may publish in the future.

Co-authorship network of co-authors of Tjeerd J. Postma

This figure shows the co-authorship network connecting the top 25 collaborators of Tjeerd J. Postma. A scholar is included among the top collaborators of Tjeerd J. Postma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tjeerd J. Postma. Tjeerd J. Postma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Frequency and burden of potentially treatable symptoms in glioma patients with stable disease 2023 ·Heliyon ·J G Röttgering, (unknown), Mathilde C.M. Kouwenhoven, (unknown), Tjeerd J. Postma, (unknown), Myra E. van Linde, Philip C. De Witt Hamer, Linda Douw, Martin Klein	1
2	Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis 2016 ·Journal of Neuro-Oncology ·(unknown), Tjeerd J. Postma, Marinus A. Blankenstein, (unknown), Maaike J. Vos, Eefje M. Sizoo, M. de Groot, Bernard M.J. Uitdehaag, Jan Buter, Martin Klein, Jaap C. Reijneveld, Jan J. Heimans	19
3	Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide 2015 ·Journal of Neuro-Oncology ·Johan A F Koekkoek, Linda Dirven, J.J. Heimans, Tjeerd J. Postma, Maaike J. Vos, Jaap C. Reijneveld, Martin Taphoorn	26
4	Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study 2015 ·Supportive Care in Cancer ·Johan A F Koekkoek, Tjeerd J. Postma, Jan J. Heimans, Jaap C. Reijneveld, Martin Taphoorn	30
5	Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients 2014 ·PLoS ONE ·Linda Brom, H. Roeline W. Pasman, Guy Widdershoven, Maurice J. D. L. van der Vorst, Jaap C. Reijneveld, Tjeerd J. Postma, Bregje D. Onwuteaka‐Philipsen	78
6	Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study 2013 ·Journal of Neuro-Oncology ·Florien Boele, Jan J. Heimans, Neil K. Aaronson, Martin Klein, Tjeerd J. Postma, Jaap C. Reijneveld, Martin Klein	40
7	Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phase 2013 ·BMJ Supportive & Palliative Care ·Eefje M. Sizoo, Johan A F Koekkoek, Tjeerd J. Postma, Jan J. Heimans, H. Roeline W. Pasman, Luc Deliëns, Martin Klein, Jaap C. Reijneveld	19
8	Symptoms and problems in the end-of-life phase of high-grade glioma patients 2010 ·Neuro-Oncology ·Eefje M. Sizoo, (unknown), Tjeerd J. Postma, H. Roeline W. Pasman, J.J. Heimans, Martin Klein, J.C. Reijneveld, Martin Taphoorn	157
9	Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial 2009 ·Journal of Clinical Oncology ·Karin Gehring, Margriet M. Sitskoorn, Chad M. Gundy, Sietske A.M. Sikkes, Martin Klein, Tjeerd J. Postma, Martin J. van den Bent, Guus Beute, Roelien H. Enting, A.C. Kappelle, Willem Boogerd, Theo Veninga, A. Twijnstra, Dolf Boerman, Martin Klein, Neil K. Aaronson	231
10	Fatigue in low-grade glioma 2008 ·Journal of Neuro-Oncology ·(unknown), Martin Klein, J.J. Heimans, Marieke Gielissen, Gijs Bleijenberg, Martin Klein, Jaap C. Reijneveld, Tjeerd J. Postma	68
11	Health-related quality of life of long-term high-grade glioma survivors 2008 ·Neuro-Oncology ·Ingeborg Bosma, Jaap C. Reijneveld, Linda Douw, Maaike J. Vos, Tjeerd J. Postma, Neil K. Aaronson, Martin J. Muller, W. Peter Vandertop, Ben J. Slotman, Martin Klein, J.J. Heimans, Martin Klein	66
12	Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer 2008 ·Annals of Oncology ·J. Sigmond, Richard J. Honeywell, Tjeerd J. Postma, Clemens M.F. Dirven, Sebastian Lange, Kasper van der Born, Adrianus C. Laan, Johannes C. Baayen, C.J. van Groeningen, Andries M. Bergman, Giuseppe Giaccone, Godefridus J. Peters	74
13	Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma 2007 ·Nuclear Medicine Communications ·Maaike J. Vos, (unknown), Otto S. Hoekstra, Tjeerd J. Postma, J.J. Heimans, Lotty Hooft	25
14	Disturbed functional connectivity in brain tumour patients: Evaluation by graph analysis of synchronization matrices 2006 ·Clinical Neurophysiology ·Fabrice Bartoloméi, Ingeborg Bosma, Martin Klein, Johannes C. Baayen, Jaap C. Reijneveld, Tjeerd J. Postma, Jan J. Heimans, Bob W. van Dijk, Jan C. de Munck, Arent de Jongh, Keith S. Cover, Cornelis J. Stam	219
15	How do brain tumors alter functional connectivity? A magnetoencephalography study 2005 ·Annals of Neurology ·Fabrice Bartoloméi, Ingeborg Bosma, Martin Klein, Johannes C. Baayen, Jaap C. Reijneveld, Tjeerd J. Postma, J.J. Heimans, Bob W. van Dijk, Jan C. de Munck, (unknown), Keith S. Cover, Cornelis J. Stam	137
16	Neurotoxic Complications of Chemotherapy in Patients with Cancer 2003 ·Drugs ·C.C.P. Verstappen, J.J. Heimans, Klaas Hoekman, Tjeerd J. Postma	324
17	A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma 2000 ·Annals of Oncology ·Tjeerd J. Postma, J.J. Heimans, (unknown), C.J. van Groeningen, Ludo F.M. Beenen, O. S. Hoekstra, (unknown), Bernard A. Zonnenberg, Martin Klein, Jan B. Vermorken	37
18	Peripheral Neuropathy Due to Biweekly Paclitaxel, Epirubicin and Cisplatin in Patients with Advanced Ovarian Cancer 1999 ·Journal of Neuro-Oncology ·Tjeerd J. Postma, Klaas Hoekman, J.M.G.H. van Riel, J.J. Heimans, Jan B. Vermorken	23
19	MR imaging of skeletal metastases from medulloblastoma 1992 ·Skeletal Radiology ·Paul R. Algra, Tjeerd J. Postma, Cornelis J. van Groeningen, Paul van der Valk, Johan L. Bloem, Jaap Valk	8
20	Routine clinical determination of carotene, vitamin E, vitamin A, 25‐hydroxy vitamin D3 and trans‐vitamin K1 in human serum by straight phase HPLC 1987 ·Biomedical Chromatography ·P.M.M. van Haard, (unknown), Tjeerd J. Postma	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact